These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35940940)

  • 1. Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey.
    Beninger P; Caubel P; Sharma L; Pajovich G; Boyd P
    Clin Ther; 2022 Sep; 44(9):1225-1236. PubMed ID: 35940940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
    Stergiopoulos S; Fehrle M; Caubel P; Tan L; Jebson L
    Pharmaceut Med; 2019 Dec; 33(6):499-510. PubMed ID: 31933240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Assessment of the SME Sector Operations during the COVID-19 Pandemic.
    Grondys K; Ślusarczyk O; Hussain HI; Androniceanu A
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey.
    Stagi L; Bocchi I; Bianco S; Sirizzotti G; Bernardini D; Calderazzo V; Pirisino G; Grisoni I; Romano S
    Ther Adv Drug Saf; 2021; 12():2042098620985991. PubMed ID: 33623659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach.
    Lavery C; Emmott J; Jeck-Thole S; Rouben P; Usher D; van der Spuij W; Woodward L
    Pharmaceut Med; 2022 Aug; 36(4):233-245. PubMed ID: 35723862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equipment and Analytical Companies Meeting Continuous Challenges May 20-21 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-831. PubMed ID: 28756844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparing for the Unprecedented: The Association of Biomolecular Resource Facilities (ABRF) Community Coronavirus Disease 2019 (COVID-19) Pandemic Response Part 1: Efforts to Sustainably Ramp Down Core Facility Activities.
    Kigenyi J; Mische SM; Porter DM; Rappoport JZ; Vinard A
    J Biomol Tech; 2020 Dec; 31(4):119-124. PubMed ID: 32999636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European pharmacovigilance: increasingly outsourced to drug companies.
    Prescrire Int; 2014 Dec; 23(155):302-3, 305-7. PubMed ID: 25629153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How small-and-medium transportation companies handle asymmetric customer relationships under COVID-19 pandemic: A multi-method study.
    Mitręga M; Choi TM
    Transp Res E Logist Transp Rev; 2021 Apr; 148():102249. PubMed ID: 36569350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Remote Inspections During the COVID-19 Health Emergency and in the Postpandemic Setting.
    Mofid S; Bolislis WR; Brading C; Hamilton N; Hardit C; Nagaoka M; Parain J; Zanta M; Kühler TC
    Clin Ther; 2021 Dec; 43(12):2046-2063. PubMed ID: 34740466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Small- and Medium-sized Enterprises Office (SME Office) at the European Medicines Agency.
    Carr M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):20-3. PubMed ID: 20101799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective of dairy producers from California, Idaho, South Dakota, and Washington: Health and business implications of the COVID-19 pandemic during the second wave.
    Valldecabres A; Wenz J; Ferreira FC; Chahine M; Dalton J; de Haro Marti M; Rovai M; Silva-Del-Río N
    J Dairy Sci; 2022 Feb; 105(2):1788-1796. PubMed ID: 34955251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective pharmacovigilance analysis: could decreased reporting of suspected adverse reactions generate future safety concerns?].
    Ferrara F; Mancaniello C; Nava L; Salierno A; Casillo R; Trama U; Nava E; Vitiello A
    Recenti Prog Med; 2022 Mar; 113(3):198-201. PubMed ID: 35315450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automation Opportunities in Pharmacovigilance: An Industry Survey.
    Ghosh R; Kempf D; Pufko A; Barrios Martinez LF; Davis CM; Sethi S
    Pharmaceut Med; 2020 Feb; 34(1):7-18. PubMed ID: 32036574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic.
    Al-Zubiedi SA; Younus M; Al-Khalidi S; Ekilo M; Alshammari TM
    Expert Opin Drug Saf; 2023 Feb; 22(2):165-174. PubMed ID: 35915555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 on digital practice in UK paediatric speech and language therapy and implications for the future: A national survey.
    Patel R; Loraine E; Gréaux M
    Int J Lang Commun Disord; 2022 Sep; 57(5):1112-1129. PubMed ID: 35925005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.